Novartis AG

NVSEF | OTC

Price Alert Chart Builder DCF Calculator

$138.25

+$4.55 (+3.40%)

Sep 21, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020
Revenue	14.84B	13.62B	13.56B	13.17B	12.59B	11.46B	11.78B	12.09B	13.94B	13.21B	13.09B	12.84B	13.09B	12.81B	13.52B	13.37B	13.29B	12.69B	13.03B	12.54B	11.62B	12.71B
Cost of Revenue	3.32B	3.23B	3.32B	3.23B	3.24B	3.03B	3.02B	3.12B	4.34B	3.93B	4.07B	3.81B	3.75B	3.86B	3.98B	3.94B	3.91B	4.04B	4.22B	3.75B	3.43B	3.72B
Gross Profit	11.51B	10.39B	10.23B	9.94B	9.35B	8.43B	8.75B	8.98B	9.6B	9.28B	9.01B	9.04B	9.33B	8.96B	9.55B	9.43B	9.38B	8.66B	8.81B	8.79B	8.19B	8.99B
Operating Income	4.86B	4.65B	3.53B	3.63B	3.95B	3.52B	2.58B	1.76B	2.92B	2.86B	1.95B	2.17B	2.23B	2.85B	2.56B	3.23B	3.48B	2.42B	2.64B	2.41B	2.35B	2.74B
Interest Income	n/a	n/a	291M	26M	75M	6M	n/a	7.25M	75M	104M	n/a	n/a	16M	20M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	4.53B	4.48B	3.29B	3.39B	3.87B	3.06B	2.38B	1.55B	2.77B	2.74B	1.74B	1.92B	2.04B	2.67B	16.95B	3.23B	3.51B	2.45B	2.56B	2.41B	2.29B	2.62B
Net Income	4.04B	3.66B	2.82B	3.19B	3.25B	2.69B	8.48B	1.76B	2.32B	2.29B	1.47B	1.57B	1.69B	2.22B	16.31B	2.76B	2.9B	2.06B	2.09B	1.94B	1.87B	2.18B
Selling & General & Admin	3.44B	3.06B	3.5B	3.13B	3.11B	2.75B	3.44B	3.09B	3.69B	3.44B	3.75B	3.41B	3.58B	3.51B	3.99B	3.62B	3.75B	3.53B	3.92B	3.42B	3.37B	3.49B
Research & Development	2.73B	2.37B	2.84B	2.39B	2.29B	2.16B	2.57B	3.93B	2.53B	2.79B	2.44B	2.74B	2.5B	2.32B	2.41B	2.38B	2.4B	2.35B	2.33B	2.15B	2.44B	2.06B
Other Expenses	481M	306M	361M	785M	n/a	n/a	n/a	n/a	n/a	n/a	35.45M	28.39M	72.68M	67.04M	2.02M	75.8M	96.52M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.65B	5.73B	6.7B	6.31B	5.4B	4.91B	6.17B	7.21B	6.68B	6.42B	7.07B	6.87B	7.11B	6.11B	6.98B	6.2B	5.9B	6.24B	6.17B	6.37B	5.84B	6.24B
Interest Expense	300.86M	274.19M	275M	264M	246M	221M	217M	222M	224M	200M	219M	206M	202M	201M	135M	202M	201M	202M	110M	209M	220M	239M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.97B	8.96B	10.03B	9.55B	8.64B	7.95B	9.19B	10.33B	11.02B	10.35B	11.14B	10.67B	10.86B	9.96B	10.96B	10.13B	9.82B	10.28B	10.39B	10.13B	9.27B	9.96B
Income Tax Expense	507M	810.37M	465M	200M	598.61M	427.43M	-261M	39M	452M	446M	275M	344M	347M	450M	645M	472M	611M	391M	460M	478M	421M	448M
Shares Outstanding (Basic)	1.95B	1.97B	1.99B	2.01B	2.03B	2.04B	2.05B	2.06B	2.08B	2.11B	2.14B	2.17B	2.2B	2.23B	2.24B	2.24B	2.24B	2.25B	2.27B	2.29B	2.29B	2.28B
Shares Outstanding (Diluted)	1.96B	1.98B	2B	2.03B	2.05B	2.06B	2.07B	2.08B	2.1B	2.12B	2.15B	2.18B	2.21B	2.24B	2.25B	2.25B	2.26B	2.27B	2.28B	2.3B	2.3B	2.29B
EPS (Basic)	2.07	1.83	1.42	1.58	1.61	1.27	4.36	0.82	1.12	1.10	0.72	0.73	0.77	1	7.29	1.23	1.29	0.91	0.92	0.85	0.82	0.96
EPS (Diluted)	2.06	1.82	1.41	1.57	1.60	1.27	4.33	0.82	1.11	1.09	0.71	0.72	0.77	0.99	7.24	1.22	1.28	0.91	0.92	0.84	0.81	0.95
EBITDA	6.08B	5.83B	5.19B	5.61B	5.12B	4.55B	4.43B	4.89B	4.82B	4.59B	4.08B	4.08B	4.08B	4.28B	18.68B	4.59B	4.84B	4.35B	4.38B	4.35B	4.21B	4.27B
EBIT	4.82B	4.68B	3.56B	3.65B	4.09B	3.27B	2.76B	1.77B	2.89B	2.72B	2.05B	2.09B	2.27B	2.87B	17.16B	3.16B	3.42B	2.65B	2.76B	2.62B	2.51B	2.86B
Depreciation & Amortization	1.26B	1.15B	1.63B	1.97B	1.17B	1.27B	1.67B	3B	1.83B	2.02B	2.03B	1.98B	1.82B	1.41B	1.53B	1.43B	1.42B	1.7B	1.62B	1.73B	1.7B	1.41B